Literature DB >> 6733753

Cell-cycle analysis using a monoclonal antibody to BrdUrd.

P N Dean, F Dolbeare, H Gratzner, G C Rice, J W Gray.   

Abstract

The flow cytometric measurement of DNA distributions of cells has many applications in biomedical research. Phase fractions estimated (calculated) from such distributions are used to study the growth characteristics of various types of cells, particularly when the cells have been exposed to perturbing agents such as chemotherapeutic drugs. For more than 10 years many methods for resolving DNA distributions into the three cell subpopulations (G1, S and G2 + M) have been reported in the literature. A new method of analysis utilizing a monoclonal antibody to bromodeoxyuridine (BrdUrd) has been developed (Gratzner, 1982; Dolbeare et al., 1983) which makes it possible in most cases to accurately determine phase fractions without resorting to mathematical models. The procedure involves the incorporation of BrdUrd by growing (DNA synthesizing) S phase cells, labelling the BrdUrd with a fluorescent monoclonal antibody, and the bivariate measurement of the antibody and of total DNA content, the latter through propidium-iodide staining. The resulting bivariate distributions clearly and simply resolve the three subpopulations. This paper describes the method and illustrates its use in the analysis of various fractions of elutriated exponentially growing Chinese hamster ovary (CHO) cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733753     DOI: 10.1111/j.1365-2184.1984.tb00601.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  29 in total

1.  Bromodeoxyuridine (BrdU) immunocytochemistry by exonuclease III (Exo III) digestion.

Authors:  W N Dinjens; J ten Kate; M H Lenders; E P van der Linden; F T Bosman
Journal:  Histochemistry       Date:  1992-10

2.  Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2.

Authors:  Junichi Kitagawa; Takeshi Hara; Hisashi Tsurumi; Soranobu Ninomiya; Kengo Ogawa; Seiji Adachi; Nobuhiro Kanemura; Senji Kasahara; Masahito Shimizu; Hisataka Moriwaki
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-31       Impact factor: 4.553

3.  Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.

Authors:  Ugur Ozerdem; William B Stallcup
Journal:  Angiogenesis       Date:  2004       Impact factor: 9.596

4.  Reversible accumulation of plant suspension cell cultures in g(1) phase and subsequent synchronous traverse of the cell cycle.

Authors:  J Conia; R G Alexander; M E Wilder; K R Richards; M E Rice; P J Jackson
Journal:  Plant Physiol       Date:  1990-12       Impact factor: 8.340

5.  Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch.

Authors:  B Stefana; D W Ray; S Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 6.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

7.  Origins of ... flow cytometry and applications in oncology.

Authors:  W Giaretti
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

8.  Labeling and tracking of mesenchymal stromal cells with EdU.

Authors:  Guiting Lin; Yun-Ching Huang; Alan W Shindel; Lia Banie; Guifang Wang; Tom F Lue; Ching-Shwun Lin
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

9.  A flow cytometric bromodeoxyuridine/DNA analysis for cytokinetics of the pancreatic cancer cell line Capan-2 after irradiation.

Authors:  B Nakata; Y S Chung; M Sowa
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.

Authors:  M Fukui; T Iwaki; H Sawa; T Inoue; I Takeshita; K Kitamura
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.